Intuitive Venture Partners | Venture Capital Firms NYC | Investment Bank New York City
Transactions News Contact Login
The FIRM Testimonials
Managing Partners Business Relationships
Investment Banking Services Proprietary Investment Opportunities
About The FIRM Testimonials Team Managing Partners Business Relationships Services Investment Banking Services Proprietary Investment Opportunities TransactionsNewsContactLogin
Intuitive Venture Partners | Venture Capital Firms NYC | Investment Bank New York City
Neurotrope Announces Cooperative Research and Development Agreement for Bryostatin-1 with the National Cancer Institute
Intuitive Venture PartnersFebruary 4, 2019neurotrope, 2019
Facebook0 Twitter LinkedIn0 Reddit Tumblr 0 Likes
Previous

Innovate Biopharmaceuticals Announces Acceptance of Three Abstracts Focusing on the Molecular Biology and Pharmacology of Larazotide for the 2019 Digestive Disease Week Conference

Intuitive Venture PartnersFebruary 25, 2019innovate biopharmaceuticals, 2019
Next

Entera Bio Announces Positive Feedback and Guidance from the US FDA

Intuitive Venture PartnersJanuary 31, 2019entera bio, 2019

Intuitive Venture Partners, LLC. • 777 Westchester Ave, Suite 101 • White Plains, NY 10604

Intuitive Venture Partners
777 Westchester Avenue,
White Plains, NY, 10604,
United States
212-612-3221 info@intuitivevp.com
Hours
Mon 8am - 5pm
Tue 8am - 5pm
Wed 8am - 5pm
Thu 8am - 5pm
Fri 8am - 5pm
 

2023 INTUITIVE VENTURE PARTNERS, LLC. ALL RIGHTS RESERVED. SECURITIES OFFERED THROUGH
NETWORK 1 FINANCIAL SECURITIES, INC., A REGISTERED BROKER-DEALER, MEMBER FINRA AND SIPC

broker-check-sml.png
Terms of UseContact